Hypothesis: Nonpalpable malignant-appearing microcalcifications discovered
by mammography geographically target the location of the most important abn
ormality within the breast. Core needle or open biopsy of these microcalcif
ications will sample or remove underlying proliferative or invasive disease
.
Design: A prospective database of 403 consecutive patients undergoing breas
t biopsy for nonpalpable abnormalities from July 1, 1994, to December 31, 1
996, was reviewed to identify biopsies done for indeterminate microcalcific
ations. Specimens showing atypical hyperplasia, carcinoma in situ, or invas
ive carcinoma were identified and reviewed by 1 pathologist. The position o
f microcalcifications larger than 100 mu m were recorded in reference to th
e histological findings.
Setting: A 450-bed referral community teaching hospital in rural Wisconsin.
Patients: Indeterminant microcalcifications were identified on mammograms i
n 167 (41.4%) of 403 patients. Sixty-one (36.5%) of 167 biopsy specimens co
ntained atypical hyperplasia, carcinoma in situ, or invasive carcinoma, and
the slides of these 61 initial breast biopsy specimens were reviewed.
Main Outcome Measures: Relationship of breast histopathological findings to
microcalcifications.
Results: In these 61 specimens, 82 areas of atypical hyperplasia, carcinoma
in situ, or invasive carcinoma were noted. The microcalcifications correla
ted with these areas in 43 (52%) of 82 areas on slide review and were prese
nt in the most important abnormality in 33 (54%) of 61 biopsy specimens.
Conclusions: Indeterminant microcalcifications identified by mammography ma
y not target the exact location of underlying breast disease. Careful evalu
ation of the entire biopsy specimen and close follow-up of patients with be
nign pathologic findings are recommended.